XENPOZYME
These highlights do not include all the information needed to use XENPOZYME safely and effectively. See full prescribing information for XENPOZYME. XENPOZYME (olipudase alfa-rpcp) for injection, for intravenous use Initial U.S. Approval: 2022
01a910ee-a33e-4be3-ac41-322d64c34311
HUMAN PRESCRIPTION DRUG LABEL
Dec 12, 2023
Genzyme Corporation
DUNS: 025322157
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
olipudase alfa-rpcp
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
olipudase alfa-rpcp
Product Details
FDA regulatory identification and product classification information